View Cart (0 items)
Pharmaceutical

Human Genome sells more anthrax drug to US government

July 22, 2009
/ Print / Reprints /
| Share More
/ Text Size+
The Associated Press reports that Human Genome Sciences Inc. announced that the U. S. government has placed an additional order for its inhaled anthrax treatment ABthrax for $151 million. The government exercised an option to buy an additional 45,000 doses of ABthrax. Human Genome Sciences will deliver the doses over a three-year period starting later this year. The company said it will receive payment as deliveries are finished. Human Genome Science developed ABthrax as part of a government program. In April, it delivered 20,000 doses of ABthrax for use in a national emergency stockpile. The company was paid $153.8 million for that delivery. Human Genome Sciences is also seeking Food and Drug Administration marketing approval for ABthrax. Earlier this month, a study published in the New England Journal of Medicine showed the drug was effective in animals.
You must login or register in order to post a comment.

Related Events